What is the 13F Pro Quality Score for DHC?

13F Pro ranks DIVERSIFIED HEALTHCARE TRUST (DHC) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View DHC's current score at https://13fpro.ai/research/DHC (free sign-up required for the full ranking).

Which hedge funds own the most DHC stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of DHC include BlackRock,, Flat Footed, Silver Point Capital L.P.. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/research/DHC as soon as new 13F filings post.

Where does 13F Pro source DHC data?

All DIVERSIFIED HEALTHCARE TRUST fundamentals and ownership data come directly from SEC EDGAR. DIVERSIFIED HEALTHCARE TRUST files with the SEC under CIK 1075415. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is DHC in?

DIVERSIFIED HEALTHCARE TRUST (DHC) is classified in the Real Estate sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/real-estate.

How often is DHC research updated on 13F Pro?

DHC's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

DIVERSIFIED HEALTHCARE TRUST(DHC)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Real Estate →Nasdaq

Institutional-grade research for retail investors

SEC EDGAR: CIK 1075415 DHC stock profile & AI dashboard →

13F Pro Quality Score

39.7/100

Rank #1,962 of 2,879 stocks

View Real Estate peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

46.0/100

Profitability

17.8/100

Balance Sheet

20.8/100

Earnings Quality

30.0/100

Free Cash Flow

35.7/100

Institutional Flow

81.1/100

Revenue Scale

57.8/100

Dilution Risk

85.1/100

DHC Stock Analysis & AI Quality Score

AI stock analysis and institutional research for DIVERSIFIED HEALTHCARE TRUST (DHC), a Real Estate sector company. 13F Pro's AI-powered ranking engine scores DHC at 39.7/100 on a 32-signal composite quality model, placing it at rank #1,962 of 2,879 stocks — the bottom half of the AI-ranked universe. DHC scores in the top quartile across institutional flow (81.1). Areas of concern include profitability (17.8) and balance sheet strength (20.8), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), DIVERSIFIED HEALTHCARE TRUST reports quarterly revenue of $366.5M, net income of $-43.3M, an operating margin of -11.7%. Top institutional holders of DHC by reported 13-F value include BlackRock,, Flat Footed, Silver Point Capital L.P., based on the most recent SEC filings. DHC trades on the Nasdaq exchange and files with the SEC under CIK 1075415. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate DHC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for DIVERSIFIED HEALTHCARE TRUST directly from SEC EDGAR. DIVERSIFIED HEALTHCARE TRUST's 13F Pro composite quality score has ranged between 39 and 40 since 2026, currently 39.7 — a stable long-term trajectory across 8 quarterly and live scoring snapshots.

Revenue

Q1 2026

$366.5M

Net Income

Q1 2026

$-43.3M

Free Cash Flow

Q1 2026

$8.3M

Operating Margin

Q1 2026

-11.7%

D/E Ratio

Q1 2026

1.51

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+9.9% YoY

$1.41BFY 2023

FY17 $1.07BFY21 $1.38BFY22 $1.28BFY23 $1.41B

Net Income

-1761.1% YoY

$-293.6MFY 2023

FY17 $147.6MFY21 $174.5MFY22 $-15.8MFY23 $-293.6M

Operating Income

—FY 2023

FY17 $275.2MFY21 —FY22 —FY23 —

EPS (Diluted)

-1657.1% YoY

$-1.23FY 2023

FY17 —FY21 $0.73FY22 $-0.07FY23 $-1.23

Total Assets

-9.3% YoY

$5.45BFY 2023

FY17 $7.29BFY21 $6.62BFY22 $6.00BFY23 $5.45B

Op. Cash Flow

+126.0% YoY

$10.5MFY 2023

FY17 $419.3MFY21 $-63.3MFY22 $-40.4MFY23 $10.5M

Metric	FY 2023	FY 2022	FY 2021	FY 2017	FY 2016	FY 2014
Revenue	$1.41B +9.9%	$1.28B -7.2%	$1.38B +28.7%	$1.07B +1.6%	$1.06B +25.2%	$844.9M
Net Income	$-293.6M -1761.1%	$-15.8M -109.0%	$174.5M +18.2%	$147.6M +4.5%	$141.3M -10.9%	$158.6M
Operating Income	—	—	—	$275.2M -9.2%	$303.1M +4.0%	$291.4M
EPS (Diluted)	$-1.23 -1657.1%	$-0.07 -109.6%	$0.73	—	—	—
Total Assets	$5.45B -9.3%	$6.00B -9.4%	$6.62B -9.2%	$7.29B +0.9%	$7.23B +21.6%	$5.94B
Operating Cash Flow	$10.5M +126.0%	$-40.4M +36.3%	$-63.3M -115.1%	$419.3M -1.2%	$424.5M +21.0%	$350.9M

AI Insight: DHC Financial Trends

DHC's equity base has eroded 25% since Q2 2024 while persistent net losses and negative operating cash flows dominate the most recent quarters.

• Equity has declined steadily from $2,149M in Q2 2024 to $1,620M in Q1 2026, a $529M erosion over six quarters.

• Net losses remain chronic, ranging from $-9M to $-164M per quarter, with no quarter achieving profitability across the entire period.

• Operating cash flow turned negative in Q1 2025 ($-3M), Q3 2025 ($-49M), and Q4 2025 ($-20M), signaling deteriorating cash generation.

• Total debt declined from $3,050M in Q4 2024 to $2,443M in Q1 2026, a $607M reduction — the one constructive balance-sheet move.

⚠ Revenue dipped to $366M in Q1 2026, the lowest in the dataset, reversing a prior upward trend from $371M to $389M.

⚠ Operating cash flow has been negative in three of the last four quarters; sustained negative OCF risks accelerating balance-sheet stress.

⚠ With equity shrinking each quarter and net losses continuing, book value dilution trajectory warrants close monitoring.

AI Insight: DHC Ratio Trends

DHC remains deeply unprofitable across all metrics, though Q3 2025's severe -43.4% operating margin trough appears to be stabilizing toward -11.7% in Q1 2026.

• Operating margin hit a trough of -43.4% in Q3 2025 but partially recovered to -11.7% in Q1 2026, still far from breakeven.

• ROIC improved from -40.0% in Q3 2025 to -4.2% in Q1 2026, though the TTM figure of -8.7% signals persistent capital destruction.

• D/E ratio edged down from 1.56 in Q4 2024 to 1.47 in Q4 2025, a modest deleveraging signal.

⚠ Q1 2025's anomalous -2.7% operating margin versus surrounding quarters suggests one-off items distorting the trend — warrants scrutiny.

⚠ ROE has been negative every quarter, reaching -38.9% in Q3 2025; sustained losses risk further equity erosion.

⚠ D/E data gaps across most quarters limit leverage visibility; full disclosure needed to assess balance sheet trajectory.

Get alerted when DHC's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for DIVERSIFIED HEALTHCARE TRUST including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of DHC

BlackRock, Inc.
$158.6M23,878,687 sh
Flat Footed LLC
$156.0M23,487,002 sh
Silver Point Capital L.P.
$103.0M15,504,810 sh
VANGUARD CAPITAL MANAGEMENT LLC
$63.7M9,599,703 sh
STATE STREET CORP
$59.7M8,986,912 sh
VANGUARD PORTFOLIO MANAGEMENT LLC
$58.6M8,817,820 sh
NOMURA HOLDINGS INC
$48.7M7,332,272 sh
GEODE CAPITAL MANAGEMENT, LLC
$43.9M6,608,497 sh
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP
$41.5M6,247,830 sh
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
$39.1M5,884,820 sh

Fund	Value	Shares
BlackRock, Inc.	$158.6M	23,878,687
Flat Footed LLC	$156.0M	23,487,002
Silver Point Capital L.P.	$103.0M	15,504,810
VANGUARD CAPITAL MANAGEMENT LLC	$63.7M	9,599,703
STATE STREET CORP	$59.7M	8,986,912
VANGUARD PORTFOLIO MANAGEMENT LLC	$58.6M	8,817,820
NOMURA HOLDINGS INC	$48.7M	7,332,272
GEODE CAPITAL MANAGEMENT, LLC	$43.9M	6,608,497
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP	$41.5M	6,247,830
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$39.1M	5,884,820

More Real Estate Companies

View all Real Estate →

AAT

American Assets Trust, Inc.

ABR

ARBOR REALTY TRUST INC

ACR

ACRES Commercial Realty Corp.

ACRE

Ares Commercial Real Estate Corp

ADAM

ADAMAS TRUST, INC.

ADC

AGREE REALTY CORP

AEI

Alset Inc.

AGNC

AGNC Investment Corp.

Put DHC on your watchlist

Track score changes the day DIVERSIFIED HEALTHCARE TRUST files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is DHC a good stock to buy?

13F Pro's AI-powered analysis of DIVERSIFIED HEALTHCARE TRUST (DHC) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Real Estate sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for DHC are available on the DHC stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own DHC?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling DHC. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of DIVERSIFIED HEALTHCARE TRUST's investment landscape.